Back

Union Korea Pharm exits rehabilitation after Bukwang’s 30 billion won investment

Verifying
  • Seoul Rehabilitation Court terminated Union Korea Pharm’s rehabilitation proceedings under the bankruptcy law.
  • Union Korea Pharm left 76 million won unpaid after repaying most claims due this year.
  • Bukwang Pharmaceutical acquired Union Korea Pharm as its largest shareholder through a 30 billion won new-share purchase.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Union Korea Pharm exits rehabilitation after Bukwang’s 30 billion won investment - CoinPost Terminal